These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20385448)

  • 21. Possible alternative treatments of Alzheimer's disease.
    Robertson DS
    Med Hypotheses; 2004; 63(6):1083-4. PubMed ID: 15504581
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapeutic strategies for Alzheimer's disease.
    Wolfe MS
    Nat Rev Drug Discov; 2002 Nov; 1(11):859-66. PubMed ID: 12415246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neurotransmitters in Alzheimer's disease].
    Kristensen MO
    Ugeskr Laeger; 1990 Jul; 152(30):2165-8. PubMed ID: 1975961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel m1 muscarinic agonists in treatment and delaying the progression of Alzheimer's disease: an unifying hypothesis.
    Fisher A; Brandeis R; Haring R; Eshhar N; Heldman E; Karton Y; Eisenberg O; Meshulam H; Marciano D; Bar-Ner N; Pittel Z
    J Physiol Paris; 1998; 92(5-6):337-40. PubMed ID: 9789833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic potential of oxidant mechanisms in Alzheimer's disease.
    Moreira PI; Smith MA; Zhu X; Santos MS; Oliveira CR; Perry G
    Expert Rev Neurother; 2004 Nov; 4(6):995-1004. PubMed ID: 15853526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug therapy in Alzheimer's disease.
    Meyer MA
    N Engl J Med; 2004 Oct; 351(18):1911-3; author reply 1911-3. PubMed ID: 15515223
    [No Abstract]   [Full Text] [Related]  

  • 27. Oxidative stress in Alzheimer's disease.
    Gibson GE; Huang HM
    Neurobiol Aging; 2005 May; 26(5):575-8. PubMed ID: 15708429
    [No Abstract]   [Full Text] [Related]  

  • 28. [Frontiers of research: Alzheimer's disease].
    Lennholm B
    Lakartidningen; 1987 May; 84(19):1645-54. PubMed ID: 3613764
    [No Abstract]   [Full Text] [Related]  

  • 29. Neurotransmitter replacement therapy in Alzheimer's disease.
    Mohr E; Mendis T; Rusk IN; Grimes JD
    J Psychiatry Neurosci; 1994 Jan; 19(1):17-23. PubMed ID: 7908537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Alzheimer's disease].
    Giménez-Roldán S
    Rev Clin Esp; 1995 Jul; 195(7):445-7. PubMed ID: 7667517
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease.
    Blass JP; Gibson GE
    Rev Neurol (Paris); 1991; 147(6-7):513-25. PubMed ID: 1962057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tacrine in relation to amino acid transmitters in Alzheimer's disease.
    Bowen DM; Steele JE; Lowe SL; Palmer AM
    Adv Neurol; 1990; 51():91-6. PubMed ID: 1967197
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapeutic treatments for Alzheimer's disease based on metal bioavailability.
    Crouch PJ; Barnham KJ; Bush AI; White AR
    Drug News Perspect; 2006 Oct; 19(8):469-74. PubMed ID: 17160147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin and Alzheimer's disease: therapeutic prospects.
    Gard PR; Rusted JM
    Expert Rev Neurother; 2004 Jan; 4(1):87-96. PubMed ID: 15853619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
    Grossberg GT; Edwards KR; Zhao Q
    J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronically mad as a hatter: anticholinergics and Alzheimer's disease pathology.
    Levey AI
    Ann Neurol; 2003 Aug; 54(2):144-6. PubMed ID: 12891665
    [No Abstract]   [Full Text] [Related]  

  • 37. [New strategies in the acute and chronic treatment of the patient with Alzheimer's dementia].
    Rocco PL
    Minerva Med; 1996 Apr; 87(4):171-7. PubMed ID: 8700341
    [No Abstract]   [Full Text] [Related]  

  • 38. Alzheimer's disease: a time for cautious optimism.
    The Lancet Neurology
    Lancet Neurol; 2015 Aug; 14(8):779. PubMed ID: 26194922
    [No Abstract]   [Full Text] [Related]  

  • 39. Erythropoietin and epidemiology of Alzheimer disease.
    Ismailov RM
    Alzheimer Dis Assoc Disord; 2013; 27(3):204-6. PubMed ID: 23314061
    [No Abstract]   [Full Text] [Related]  

  • 40. Rebalancing calcium in Alzheimer disease.
    Kingwell K
    Nat Rev Drug Discov; 2024 Aug; 23(8):580. PubMed ID: 38969746
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.